Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 12(1): 14926, 2022 Sep 02.
Artigo em Inglês | MEDLINE | ID: mdl-36056060

RESUMO

Amoebae from the genus Acanthamoeba are important pathogens responsible for severe illnesses in humans such as Acanthamoeba keratitis and granulomatous amoebic encephalitis. In the last few decades, AK diagnoses have steadily increased. Most patients suffering from AK were contact lens users and the infection was related to poor hygiene. However, therapy is not yet well established, and treatments may last for several months due to resistance. Moreover, these treatments have been described to generate cytotoxicity. Therefore, there is an urgent need to develop new therapeutic strategies against AK. In this study, the amoebicidal activity of different generation cationic carbosilane dendrons derived with 4-phenylbutyric acid was demonstrated against Acanthamoeba polyphaga and Acanthamoeba griffini trophozoites and cysts. In addition, the combination of chlorhexidine digluconate and the most effective dendron (ArCO2G2(SNMe3I)4) showed an in vitro effect against Acanthamoeba trophozoites and cysts, reducing the minimal trophozoite amoebicidal concentration as well as concentrations with cysticidal activity.


Assuntos
Acanthamoeba castellanii , Acanthamoeba , Amebicidas , Cistos , Dendrímeros , Amebicidas/farmacologia , Animais , Cátions/farmacologia , Dendrímeros/farmacologia , Humanos , Fenilbutiratos , Silanos , Trofozoítos
2.
Parasitol Res ; 118(6): 1953-1961, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31069536

RESUMO

The genus Acanthamoeba can cause Acanthamoeba keratitis (AK) and granulomatous amoebic encephalitis (GAE). The treatment of these illnesses is hampered by the existence of a resistance stage that many times causes infection relapses. In an attempt to add new agents to our chemotherapeutic arsenal against acanthamebiasis, two Acanthamoeba isolates were treated in vitro with newly synthesized biguanide dendrimers. Trophozoite viability analysis and ultrastructural studies showed that dendrimers prevent encystment by lysing the cellular membrane of the amoeba. Moreover, one of the dendrimers showed low toxicity when tested on mammalian cell cultures, which suggest that it might be eventually used as an amoebicidal drug or as a disinfection compound in contact lens solutions.


Assuntos
Ceratite por Acanthamoeba/tratamento farmacológico , Acanthamoeba/efeitos dos fármacos , Amebicidas/farmacologia , Biguanidas/farmacologia , Clorexidina/análogos & derivados , Dendrímeros/farmacologia , Encefalite/tratamento farmacológico , Acanthamoeba/classificação , Acanthamoeba/isolamento & purificação , Animais , Linhagem Celular Tumoral , Clorexidina/farmacologia , Soluções para Lentes de Contato , Encefalite/parasitologia , Células HeLa , Humanos , Trofozoítos/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA